Background
Methods
Study design
Assumptions for the costs of G6PDd among male individuals infected by P. vivax in the Brazilian Amazon, 2009, 2010 and 2011
-
Diagnosis of vivax malaria: performed by blood microscopy test, using the Walker method of thick blood smear;
-
Microscope and microscope maintenance: considered as one microscope and one maintenance per year per reporting unit, assuming that all reporting units identified in Information System for Epidemiological Surveillance of Malaria (SIVEP/MALÁRIA) provided the diagnosis of P. vivax malaria;
-
Training of microscopists: one training period per year per municipality that reported case of vivax malaria among men;
-
Health worker: the cost of diagnosis and treatment considered the health agent involved in active demand of new cases and the microscopist involved in providing the diagnosis and medication. The monthly salary of the microscopist and health worker were based on the salary of Amazonas State, both relating to the auxiliary level career with workload of 40 hours per week.
-
Costs of specialized medical appointment: one medical appointment specialized in admission and another after hospital discharge.
-
Tests performed before and after hospitalization: all carrying G6PDd with severe adverse events and requiring hospital care were submitted to pre-admission tests. Among them, the patients released from hospital did further tests during follow-up monitoring.
-
Hospital costs, where all patients with severe adverse effects were hospitalized:
-
Professional costs were calculated based on time spent per patient/day per doctor, nurse and nursing technician, assuming the average salaries in Amazonas state;
-
Hospital food: six meals a day for each patient, assuming values of the FMT-HVD, Amazonas State.
Definition of cases and sources of information
Items
|
Years
| |||
---|---|---|---|---|
2009
|
2010
|
2011
|
Sources
| |
Number of males submitted to thick blood smear test in Brazilian Amazon1
| 1,596,725 | 1,643,714 | 1,781,812 | [8] |
Number of males with G6PDd submitted to thick blood smear test in Brazilian Amazon2
| 71,853 | 73,967 | 80,182 | |
Number of males submitted to thick blood smear test in Brazilian Amazon by active demand3
| 878,473 | 903,808 | 968,145 | [8] |
Number of males with G6PDd submitted to thick blood smear test in Brazilian Amazon by active demand4
| 39,531 | 40,671 | 43,567 | |
Number of vivax malaria cases among males | 155,413 | 173,559 | 141,803 | [8] |
Number of males with G6PDd among those diagnosed with P. vivax
5
| 6,994 | 7,810 | 6,381 | |
Number of units that diagnosed cases of vivax malaria | 1,814 | 1,797 | 1,639 | [8] |
Number of municipalities in Brazilian Amazon that reported cases of vivax malaria among men | 524 | 511 | 472 | [8] |
Number of males hospitalized with G6PDd after treatment with PQ6
| 6,594 | 7,364 | 6,016 | |
Number of deaths attributed to the use of PQ among carrier men of G6PDd 7
| 189 | 211 | 172 |
Items
|
Reference values - base-case (US$)/year
|
Sources
| |||||
---|---|---|---|---|---|---|---|
A - Diagnosis of vivax malaria
|
2009
|
2010
|
2011
| ||||
All males
|
Males with G6PDd
1
|
All males
|
Males with G6PDd
1
|
All males
|
Males with G6PDd
1
| ||
- Thick blood smear | 1,814,409.17 | 81,648.41 | 2,202,950.33 | 99,132.77 | 2,665,142.63 | 119,931.42 | [24] |
- Microscope | 1,096,068.22 | 49,323.07 | 1,280,603.64 | 57,627.16 | 1,303,580.23 | 58,661.11 | [25] |
- Microscope maintenance | 83,204.59 | 3,744.21 | 97,213.02 | 4,374.59 | 98,957.22 | 4,453.08 | [30] |
- Health workers | 3,912,989.04 | 176,084.51 | 4,754,380.68 | 213,947.13 | 5,889,094.46 | 265,009.25 | [31] |
- Annual training (microscopist) | 7,223,201.42 | 325,044.07 | 8,307,793.49 | 373,850.70 | 8,564,439.54 | 385,399.78 | [30] |
- Total costs (A) | 14,129,872.43 | 635,844.27 | 16,642.941.17 | 748,932.35 | 18,521,214.09 | 833,454.64 | |
B – Drug treatment for
P. vivax
|
2009
|
2010
|
2011
| ||||
All males
|
Males with G6PDd
|
All males
|
Males with G6PDd
|
All males
|
Males with G6PDd
| ||
- Therapeutic scheme | 41,284.62 | 1,857.92 | 58,635.90 | 2,638.56 | 41,415.28 | 1,863.65 | [32] |
C – Assistance to carriers of G6PDd treated with PQ
|
2009
|
2010
|
2011
| ||||
Males with G6PDd
|
Males with G6PDd
|
Males with G6PDd
| |||||
- Pre-admission tests | 74,659.04 | 94,701.04 | 82,037.35 | ||||
- Medical appointments | 66,271.36 | 83,681.82 | 72,047.90 | [20] | |||
- Hospitalization2
| 3,530,482.47 | 4,457,992.22 | 3,838,217.22 | [20] | |||
- Hospital food | 432,757.87 | 580,711.73 | 538,733.13 | [33] | |||
- Health workers | 141,826.64 | 188,506.44 | 175,245.56 | [34] | |||
- Tests performed after hospitalization | 64,235.79 | 81,530.89 | 70,688.14 | ||||
- Total costs (C) | 4,310,233.17 | 5,487,124.14 | 4,776,969.30 | ||||
- Total costs (A + B + C)3
| 4,947,935.36 | 6,238,695.05 | 5,612,287.59 |
Estimate of costs
Diagnosis and treatment of vivax malaria among carriers of G6PDd
Deficiency of G6PD among men infected by Plasmodium vivax submitted to treatment with PQ
Tests performed in carriers of G6PDd with severe adverse events associated with the use of primaquina
-
Pre-admission tests: thick blood smear, complete blood count, levels of: serum creatinine, blood urea nitrogen, SGOT and SGPT, total bilirubin and fractions, complete urinalysis and reticulocyte count.
-
Tests carried out after release from hospital: thick blood smear, complete blood count, levels of: serum creatinine, blood urea nitrogen, SGOT and SGPT, total bilirubin and fractions, complete urinalysis and testing for G6PDd.
Analysis of sensitivity
Results
Items
|
Base-case (US$)
|
Lower limit (US$)
|
Upper limit (US$)
|
---|---|---|---|
Diagnosis of vivax malaria1
| 739,410.42 | 532,081.82 | 920,943.11 |
Therapeutic scheme1
| 2,120.04 | 2,120.04 | 2,120.04 |
Assistance to carriers of G6PDd treated with PQ1
| 4,858,108.87 | 3,905,310.28 | 5,779,556.08 |
Total cost |
5,599,639.33
|
4,439,512.14
|
6,702,619.24
|